Performance of the PRIMaCY sudden death risk prediction model for childhood hypertrophic cardiomyopathy: implications for implantable cardioverter-defibrillator decision-making.
Journal Information
Full Title: Europace
Abbreviation: Europace
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Conflict of interest: P.M.E. declares consultancies for Pfizer and Sarepta. J.P.K. declares consultancies for Tenaya, Cytokinetics, and DiNAQOR. The other authors declare no conflict of interest."
Funding Disclosure
Evidence found in paper:
"Funding G.N., E.F. and J.P.K. are supported by Great Ormond Street Hospital Children’s Charity. E.F. and J.P.K. are supported by Max’s Foundation. J.P.K. is supported by a Medical Research Council Clinical (MRC)—National Institute for Health Research (NIHR) Clinical Academic Research Partnership (CARP) award (MR/T024062/1). This work is (partly) funded by the NIHR GOSH BRC."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025